AMSTERDAM (Reuters) - Philips, Dutch healthcare technology company, said on Wednesday it would suspend manufacturing some defibrillators in the United States and continue making others under heightened scrutiny by the U.S. Food and Drug Administration.
No comments:
Post a Comment